{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:01:43Z","timestamp":1780502503187,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Research & Clinical Practice"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.orcp.2023.09.003","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T05:13:11Z","timestamp":1695877991000},"page":"390-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Increased risk of cardiometabolic disease in normal-weight individuals with non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"17","author":[{"given":"Myong-Won","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngseob","family":"Eum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3465-8965","authenticated-orcid":false,"given":"Hyun Chul","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.orcp.2023.09.003_bib1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.orcp.2023.09.003_bib2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.orcp.2023.09.003_bib3","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/ATVBAHA.114.305200","article-title":"Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study","volume":"35","author":"Long","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.orcp.2023.09.003_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/1471-230X-8-40","article-title":"Resveratrol inhibits nonalcoholic fatty liver disease in rats","volume":"8","author":"Bujanda","year":"2008","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.orcp.2023.09.003_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2023.01.006","article-title":"Nonalcoholic fatty liver disease is independently associated with higher all-cause and cause-specific mortality","author":"de Avila","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.orcp.2023.09.003_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/DMSO.S80364","article-title":"Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: a large cross-sectional and prospective validation study","volume":"8","author":"Lesmana","year":"2015","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.orcp.2023.09.003_bib7","doi-asserted-by":"crossref","first-page":"E402","DOI":"10.1152\/ajpendo.00331.2010","article-title":"Metabolic pathways promoting intrahepatic fatty acid accumulation in methionine and choline deficiency: implications for the pathogenesis of steatohepatitis","volume":"300","author":"Macfarlane","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.orcp.2023.09.003_bib8","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jhep.2015.07.010","article-title":"Relationship of sitting time and physical activity with non-alcoholic fatty liver disease","volume":"63","author":"Ryu","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.orcp.2023.09.003_bib9","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.2337\/dc13-2229","article-title":"Pregravid liver enzyme levels and risk of gestational diabetes mellitus during a subsequent pregnancy","volume":"37","author":"Sridhar","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.orcp.2023.09.003_bib10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/hep.31608","article-title":"Hepatic fibrosis associates with multiple cardiometabolic disease risk factors: the framingham heart study","volume":"73","author":"Long","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.orcp.2023.09.003_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.orcp.2023.02.001","article-title":"Metabolically unhealthy phenotype in adults with normal weight: is cardiometabolic health worse off when compared to adults with obesity","author":"Seo","year":"2023","journal-title":"Obes Res Clin Pr"},{"key":"10.1016\/j.orcp.2023.09.003_bib12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1159\/000514953","article-title":"NASH\/Liver fibrosis prevalence and incidence of nonliver comorbidities among people with nafld and incidence of NAFLD by metabolic comorbidities: lessons from South Korea","volume":"39","author":"Park","year":"2021","journal-title":"Dig Dis"},{"key":"10.1016\/j.orcp.2023.09.003_bib13","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.orcp.2023.09.003_bib14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.orcp.2023.02.001","article-title":"Metabolically unhealthy phenotype in adults with normal weight: is cardiometabolic health worse off when compared to adults with obesity","volume":"17","author":"Seo","year":"2023","journal-title":"Obes Res Clin Pr"},{"key":"10.1016\/j.orcp.2023.09.003_bib15","doi-asserted-by":"crossref","unstructured":"Diagnosis and classification of diabetes mellitus Diabetes Care 34 Suppl 1 2011 S62 S69.","DOI":"10.2337\/dc11-S062"},{"key":"10.1016\/j.orcp.2023.09.003_bib16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.orcp.2023.09.003_bib17","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.21037\/atm-20-2951","article-title":"Development of a simple nonalcoholic fatty liver disease scoring system indicative of metabolic risks and insulin resistance","volume":"8","author":"Jeong","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.orcp.2023.09.003_bib18","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/HJH.0000000000000935","article-title":"Estimated carotid-femoral pulse wave velocity has similar predictive value as measured carotid-femoral pulse wave velocity","volume":"34","author":"Greve","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.orcp.2023.09.003_bib19","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/dc09-1825","article-title":"Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk","volume":"33","author":"Amato","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.orcp.2023.09.003_bib20","doi-asserted-by":"crossref","first-page":"802","DOI":"10.7326\/0003-4819-139-10-200311180-00007","article-title":"Use of metabolic markers to identify overweight individuals who are insulin resistant","volume":"139","author":"McLaughlin","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.orcp.2023.09.003_bib21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3346\/jkms.2006.21.4.695","article-title":"Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults","volume":"21","author":"Lee","year":"2006","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.orcp.2023.09.003_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-017-0409-6","article-title":"The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease","volume":"16","author":"Zhang","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.orcp.2023.09.003_bib23","first-page":"1","article-title":"Association of chronotype with eating habits and anthropometric measures in a sample of Iranian adults","author":"Zeraattalab-Motlagh","year":"2022","journal-title":"Br J Nutr"},{"key":"10.1016\/j.orcp.2023.09.003_bib24","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.orcp.2023.09.003_bib25","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.orcp.2023.09.003_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33419-6","article-title":"Association between body mass index and fatty liver risk: a dose-response analysis","volume":"8","author":"Fan","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.orcp.2023.09.003_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000000329","article-title":"Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study)","author":"Nabi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.orcp.2023.09.003_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/jgh.16049","article-title":"Epidemiology and prevalence of lean nonalcoholic fatty liver disease and associated cirrhosis, hepatocellular carcinoma, and cardiovascular outcomes in the United States: a population-based study and review of literature","volume":"38","author":"Almomani","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.orcp.2023.09.003_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/apt.14112","article-title":"Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients","volume":"46","author":"Sookoian","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.orcp.2023.09.003_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2020.100097","article-title":"The risk of cardiometabolic disorders in lean non-alcoholic fatty liver disease: a longitudinal study","volume":"4","author":"Aneni","year":"2020","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.orcp.2023.09.003_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/apt.17424","article-title":"Higher mortality among lean patients with non-alcoholic fatty liver disease despite fewer metabolic comorbidities","author":"Wijarnpreecha","year":"2023","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Obesity Research & Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871403X23001084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871403X23001084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:30:45Z","timestamp":1761730245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871403X23001084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1871403X23001084"],"URL":"https:\/\/doi.org\/10.1016\/j.orcp.2023.09.003","relation":{},"ISSN":["1871-403X"],"issn-type":[{"value":"1871-403X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased risk of cardiometabolic disease in normal-weight individuals with non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Obesity Research & Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.orcp.2023.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Asia Oceania Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}